Your browser doesn't support javascript.
loading
Change in sweat chloride as a clinical end point in cystic fibrosis clinical trials: the ivacaftor experience.
Durmowicz, Anthony G; Witzmann, Kimberly A; Rosebraugh, Curtis J; Chowdhury, Badrul A.
Afiliação
  • Durmowicz AG; Division of Pulmonary, Allergy, and Rheumatology Products, Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD. Electronic address: anthony.durmowicz@fda.hhs.gov.
  • Witzmann KA; Division of Pulmonary, Allergy, and Rheumatology Products, Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
  • Rosebraugh CJ; Office of Drug Evaluation II, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
  • Chowdhury BA; Division of Pulmonary, Allergy, and Rheumatology Products, Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
Chest ; 143(1): 14-18, 2013 Jan.
Article em En | MEDLINE | ID: mdl-23276841
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Suor / Cloretos / Avaliação de Resultados em Cuidados de Saúde / Quinolonas / Fibrose Cística / Aminofenóis Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2013 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Suor / Cloretos / Avaliação de Resultados em Cuidados de Saúde / Quinolonas / Fibrose Cística / Aminofenóis Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2013 Tipo de documento: Article